In the field of drug discovery and development, how to accurately and efficiently assess the effects and safety of drugs has always been the goal of scientists. InnoModels' PDC high-throughput in vitro drug efficacy platform brings a new breakthrough in this field with its unique technology and advantages.
1. Highly Consistent Primary Cells
Using the digestion products of PDX (patient-derived xenograft) models, the PDC high-throughput in vitro pharmacodynamic platform of InnoModels Biotechnology has successfully obtained primary cells that are highly consistent with patients. These primary cells not only have complex cell subpopulations, but also retain authentic biological characteristics, allowing the drug to act and respond more closely to the clinical situation. Compared with traditional cell lines, such highly consistent primary cells provide more accurate and reliable experimental data for drug development.
2、Efficient drug screening capability
The platform has a powerful high-throughput drug screening capability, which allows for rapid and accurate evaluation of a large number of drugs. By comparing the subject drug with counterpart drugs (e.g., drugs with similar mechanism of action or standardized therapeutic drugs), researchers can quickly screen out potential drug candidates and provide strong support for subsequent clinical trials.

3、Predicting the clinical effectiveness of drugs
In addition to drug screening, the platform can also predict the clinical effectiveness of drugs. By comparing the performance of the subject drug in in vitro experiments with the efficacy data of known drugs, researchers can initially determine the success rate of the drug in clinical trials. This prediction capability greatly shortens the drug development cycle, reduces R&D costs, and brings higher economic benefits to pharmaceutical companies.
4、Wide range of applications
InnoModels' PDC high-throughput in vitro drug efficacy platform is applicable to a wide range of drug development types, including antitumor drugs, antiviral drugs, and neurological drugs. In addition, the platform can also be used to evaluate drug resistance and safety, providing comprehensive technical support for drug development.
5. Conclusion
To summarize, the PDC high-throughput in vitro drug efficacy platform of InnoModels Biotechnology has brought significant technological innovation to the field of drug discovery and development with its high consistency of primary cells, highly efficient drug screening capability, predictive drug clinical efficacy, and wide range of applications. With the continuous optimization and improvement of the platform, it is believed that it will bring more innovations to pharmaceutical companies and research institutes, and promote the continuous development of the drug R&D field.